20–21 Jan 2022
Birla Institute of Technology
Asia/Kolkata timezone

Computer-aided drug discovery: From small compounds to protein inhibitors against tyrosine kinase of EGFR for cancer therapy

21 Jan 2022, 09:30
1h
Birla Institute of Technology

Birla Institute of Technology

Mesra, Ranchi 835 215, Jharkhand, India
Keynote Lecture Interdisciplinary Keynote Lecture

Speaker

Dr Kiattawee Choowongkomon (Kasetsart University, Bangkok)

Description

Computational studies are an essential part of research in Biochemistry today. The goal of theoretical investigation of biochemical processes is to gain a deeper insight into the molecular mechanism behind the process of study. It can further be used to predict the results of experiments. Protein Bioinformatics is a useful technique to understand biochemical processes of proteins on various levels including protein modeling, protein docking, and protein molecular dynamics. In our group, we focus on the anticancer targeted protein, the epidermal growth factor receptor (EGFR). This protein plays a crucial role in cellular signaling pathways that regulates key functions, especially proliferation. The EGFR abnormalities have been associated with several types of human cancer. Nowadays, there are cancer-treated drugs that inhibit the activity of tyrosine kinase (TK) domain of EGFR – a signaling part of this protein. However, each drug specifically treats with each cancer type and some tumor patients have resisted to those drugs. A discovery of better new efficient inhibitors is extremely needed. The virtual screening of medicinal plant compound databases against EGFR-TK have been used to discover new inhibitors. These compounds were tested on enzymatic inhibiting assay and non-small cell lung cancer cells, A549.

Primary author

Dr Kiattawee Choowongkomon (Kasetsart University, Bangkok)

Presentation materials

There are no materials yet.